Who are Escient Pharmaceuticals's investors?

Escient Pharmaceuticals's investors include NEA, Incyte, Abingworth Bioventures, Forge Life Science Par, Redmile Group, Perceptive Advisors.

When was Escient Pharmaceuticals founded?

Escient Pharmaceuticals was founded in 2018.

Where is Escient Pharmaceuticals headquartered?

Escient Pharmaceuticals is headquartered in San Diego, California, United States.

What industry is Escient Pharmaceuticals in?

Escient Pharmaceuticals operates in Pharmaceutical.

How many employees does Escient Pharmaceuticals have?

Escient Pharmaceuticals has 51-200 employees.

Escient Pharmaceuticals

Acquired

San Diego, United States · Founded 2018

Pharmaceutical

Headquarters: San Diego, California
Employees: 51–200
Founded: 2018
Business Model: B2B

Website: escientpharma.com
Last Round: Series CNov 2022
Rounds: 3

About

Escient Pharmaceuticals was a San Diego-based clinical-stage biopharmaceutical company focused on developing oral small molecule therapeutics for mast cell-mediated disorders including chronic urticaria, cholestatic pruritus, and atopic dermatitis. Its lead program EP262 targeted MRGPRX2 receptors. Escient was acquired by Incyte Corporation for $750 million in 2024.

Summary

Escient Pharmaceuticals is a Pharmaceutical company based in San Diego, United States, founded in 2018. Its most recent funding was a Series C round in Nov 2022. Investors include NEA, Incyte and Abingworth Bioventures.